SLC5A2 and keratitis: Accordingly, it is reasonable that the application of SGLT2 inhibitors suppress the inflammation, glucose-induced oxidative stress and cell death 3, 23, 35, thus the development of both superficial keratopathy and infectious keratitis become fewer.